Over the past few decades, a large body of work generated by developmental and stem cell biologists has provided an understanding of how to control stem and progenitor cell behaviours, such as self-renewal and differentiation along specific tissue lineages, at a molecular level. At the same time, research in the field of regenerative medicine has shown that organs can be repaired by dissociated stem cells that differentiate into one or more of the required mature cell types 1 . Taken together, these developments helped to cultivate the idea that stem cells could be used to re-create organs in vitro. Indeed, the past decade has seen a marked shift towards the use of organoids for studying tissue and organ biology 2-4 . Nevertheless, the history of organoids could be considered to date back to the 1970s, when Howard Green and his colleagues demonstrated that co-cultures of primary human keratinocytes and 3T3 fibroblasts form stratified squamous epithelial colonies resembling the human epidermis, with cell proliferation in the basal layers and keratinization in the upper layers 5 . However, similar to traditional mammalian cell culture, this and many subsequent approaches involved growing cells on artificial 2D surfaces, which precludes the study of behaviours that are intrinsically linked to the 3D organization of cells into tissues and organs.
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. Taken together, these developments helped to cultivate the idea that stem cells could be used to re-create organs in vitro. Indeed, the past decade has seen a marked shift towards the use of organoids for studying tissue and organ biology [2] [3] [4] . Nevertheless, the history of organoids could be considered to date back to the 1970s, when Howard Green and his colleagues demonstrated that co-cultures of primary human keratinocytes and 3T3 fibroblasts form stratified squamous epithelial colonies resembling the human epidermis, with cell proliferation in the basal layers and keratinization in the upper layers 5 . However, similar to traditional mammalian cell culture, this and many subsequent approaches involved growing cells on artificial 2D surfaces, which precludes the study of behaviours that are intrinsically linked to the 3D organization of cells into tissues and organs.
The establishment of 3D culture systems, which resulted from a better understanding of extracellular matrix (ECM) biology 6, 7 and the development of methods for culturing cells in suspension 8, 9 , played a key part in enabling organoid culture. Among the first examples of what today might legitimately be considered an organoid were structures derived from the mammary gland by Mina Bissell and colleagues, which showed that in vitro morphogenesis could be observed in 3D laminin-rich matrices 10, 11 . These cultures resulted in functional alveolus-like structures characterized by epithelial polarization and directional secretion, which developed by virtue of their interaction with the basement membrane 10 . However, it was perhaps the groundbreaking work by the groups of Yoshiki Sasai 12 and Hans Clevers 13 that kick-started the organoid field. Clevers and co-workers demonstrated that intestinal organoids 13 could be derived from intestinal adult stem cells (ASCs) whereas Sasai and colleagues showed that pluripotent stem cells (PSCs) could be used to recapitulate in vitro the development of cortical tissues 14 and the optic cup 12 . Their work promoted the idea that stem cells have the intrinsic ability to self-organize into 3D structures that resemble in vivo organs, which remains one of the cardinal concepts underlying organoid biology. Subsequent to these pioneering studies, other scientists have succeeded in generating organoids from a wealth of different cellular sources and from different species (Table 1) .
Over the years, the term organoid has been used to define different types of in vitro cultures, from tissue explants [15] [16] [17] to organ-on-chip systems 18 , with the general meaning being 'similar to an organ'. However, this broad definition may lead to confusion 19 . In this Review, we consider organoids to be complex 3D structures that display architectures and functionalities similar to in vivo organs and that develop from stem cells or organ-specific progenitors through a self-organization process 2, 3 . Here, we describe the main classes of organoids and how they can be derived and discuss their existing and emerging applications in the fields of basic biology, disease modelling and regenerative medicine. We highlight some of the key challenges that the field Organoids Stem cell-derived or progenitor cell-derived 3D structures that, on much smaller scales, re-create important aspects of the 3D anatomy and multicellular repertoire of their physiological counterparts and that can recapitulate basic tissue-level functions.
Progress and potential in organoid research
is encountering and provide a forward-looking framework for how multidisciplinary approaches could be used to build next-generation organoid platforms. In particular, we take inspiration from tissue engineering 20 , a field classically focused on the design and fabrication of biocompatible materials that serve as cell-instructive scaffolds for tissue reconstruction. Tissue engineers have conceived a wide range of technologies to augment tissue regeneration that could further improve organoid cultures. We do not discuss in detail specific organoid types or their applications in specific fields and instead refer interested readers to several excellent recent reviews on these topics [21] [22] [23] [24] [25] [26] .
Deriving organoids
Organoid development usually involves the self-organization of a fairly homogeneous cell population. Selforganization can be defined as the capacity of a cellular system that initially lacks an ordered structure to spatially rearrange under the guidance of system-autonomous mechanisms, even if exposed to a uniform signalling environment 4 . Much of what is known about this process comes from decades of research in the field of developmental biology. Conceptually, the self-organization process can be broken down into self-patterning events and morphogenetic rearrangements 4 . Self-patterning is the formation of patterns of cell differentiation in an initially homogeneous system that result from system-autonomous mechanisms and local intercellular communication. Self-patterning usually starts with a symmetry-breaking event 4, 27 , for which interplay between a number of different mechanisms has been proposed, including reaction-diffusion mechanisms 28, 29 , bistability of regulatory networks 30 and asymmetric cell division 4 . Many of these mechanisms rely on positive and negative feedback circuits and crosstalk between them [28] [29] [30] . Morphogenetic rearrangements result from sorting of different cell types within a tissue and from higher-level reorganization of the system's architecture. Cell sorting is mediated by physical interactions between different cell types, which involve differences in cell-cell adhesion, cortical tension and/or contractility and cell motility 4, 31 . Architectural rearrangements are sustained by system-intrinsic mechanics resulting from changes in cell shape, cell contraction, cell movement or differential tissue expansion 4 . Successful derivation of organoids relies on recapitulating these processes and requires careful consideration of three main features: the physical characteristics of the culture environment; the requirement for system-autonomous (that is, endogenous) and/or exogenous signals; and the starting cell type and system conditions. Choices made regarding each of these features can affect the characteristics of the final organoid.
Physical characteristics of the culture environment.
The most common way to promote the 3D characteristic of organoids is to use solid ECMs that support cell growth and to which cells can adhere (Fig. 1a) . Matrigel, a natural ECM purified from Engelbreth-Holm-Swarm mouse sarcoma 7 , is the most widely used matrix for 3D organoid derivation. Intestinal 13 , cerebral 32 , gastric 33 and mammary gland 17 organoids are only some of the examples that have been successfully generated using Matrigel or similar animal-derived hydrogels that mimic basement membranes. There have also been some rare examples of the use of collagen type I matrices for derivation of mammary gland 34 and intestinal 35 organoids. The main advantage of these natural matrices is the presence of a complex mix of ECM components and growth factors, which makes cell growth and differentiation very efficient. However, this complexity and the variability in composition make it more difficult to control the culture environment and may lower reproducibility. For these reasons, chemically defined hydrogels have been recently introduced to support intestinal 36 and cerebral 37 organoid culture as a substitute for the less well-defined natural matrices. These hydrogels allow the biochemistry and mechanics of the culture environment to be controlled but are inherently less bioactive and need to be customized to match the specific requirements of different organoids. A different strategy, which has been adopted for the derivation of optic cup 12 , cerebral 14 , cerebellar 38 and hippocampal 39 organoids, is the culture of 3D cell aggregates in suspension (Fig. 1a) . Although the suspension culture approach does not make use of a solid scaffold for cell embedding, in some cases low concentrations of Matrigel are added to promote the formation of polarized epithelial structures 12 . Kidney organoids 40, 41 have been generated using an air-liquid interface method in which cells are cultured in the form of a pellet on a thin, microporous membrane, with cell culture medium only on the basal side of the membrane (Fig. 1a) . Cell pellets subsequently self-organize into a multi-layered structure that resembles the microarchitecture of the native kidney.
At this point in time, the decision to use a specific organoid derivation protocol is largely driven by empirical considerations. Indeed, systematic comparisons of different protocols for deriving a specific organoid type are lacking, which means it is not yet possible to appreciate the relative strengths, weaknesses and applications of each protocol.
Endogenous and exogenous signals. Most organoids are derived from a starting cell population that has been exposed to specific morphogens at defined time points, which results in the activation of desired developmental signalling pathways. In turn, these signals can trigger self-organization, but only if all the necessary components are present in the system: missing components must be provided exogenously for self-organization to proceed appropriately.
The derivation of some organoids relies almost exclusively on endogenous signals (Fig. 1b) . For example, mouse optic cup organoids are derived from mouse PSCs that are aggregated and cultured in a serum-free medium containing low levels of growth factors. These conditions support the formation of a uniform neuroepithelium (NE), after which self-patterning mechanisms specify spatially separated domains of neural retina (NR) and retinal pigmented epithelium (RPE) (Fig. 1b) 
Organ-on-chip
Microfluidic cell culture device that contains perfused chambers in which living cells are arranged to simulate tissue-level and organ-level physiology.
Symmetry-breaking
The first identifiable event that triggers the formation of an asymmetric system from an initially homogeneous (symmetric) state.
Reaction-diffusion mechanisms
Mathematical models that describe the dynamics of pattern formation in terms of local production and diffusion of activators and inhibitors and their interactions.
Bistability of regulatory networks
The behaviour of biological systems in which positive and negative feedback between networks of regulatory elements results in only one of two mutually exclusive outcomes.
Asymmetric cell division
The mechanism of cellular division by which the mother cell produces two daughter cells with different cell fates.
Air-liquid interface
a method for cell culture that is typically used for epithelial cells and in which a porous filter is used to expose basal cell layers to the cell culture medium and external cell layers to the air.
Morphogens
biomolecules that act in a concentration-dependent manner to determine cell fate choices and tissue patterning in vivo. nature reviews | GeneTicS . Thus, the starting cell population already possesses all the required components to self-organize into an optic cup, likely following its default developmental trajectory. Nevertheless, it should be noted that although no additional factors are supplied during derivation of these organoids, it is possible that a small quantity of exogenous signals could be present in the minimal amount of Matrigel used in the procedure.
The majority of organoid derivation protocols do require that specific exogenous signals are provided because the initial cellular system does not contain all the essential components to undergo the desired self-organization process. In some cases, exogenous signals are necessary only for induction of initial cell types, which then rely on system-autonomous signals to undergo the remaining steps of self-organization. For example, human PSCs (hPSCs) must be exogenously stimulated with specific growth factors to form a mixed population of ureteric epithelium and metanephric mesenchyme cells 40 , which will then self-organize into kidney organoids without addition of further factors to the medium 25, 40 (Fig. 1b) .
Finally, for many organoids, the cellular system must be stimulated with appropriate and specific exogenous signals throughout the derivation process. hPSC-derived gastric organoids are just one of several such examples: exogenously supplied factors are necessary to push hPSC-derived definitive endoderm cells towards a posterior foregut fate 33 (Fig. 1b) ; further exogenous stimulation is then required to guide cells towards an antral or fundic gastric epithelial fate and to direct growth, morphogenesis and differentiation into functional gastric cell types 33, 42 . Although these considerations apply to all types of organoids, PSC-derived organoids in particular often require timed exposure to specific factors to guide the system through the desired developmental trajectories. The decision on which specific factors to use, and when they are applied, is generally informed by the current understanding of relevant in vivo developmental mechanisms.
Starting cell type and initial culture conditions. Protocols for the derivation of different organoids vary in the starting state of the cell population (Fig. 1c) . Depending on the initial conditions, a cell ensemble will undergo all or only some of the steps involved in self-organization. When organoids are derived from a single cell type (as is the case for optic cup or small intestine organoids), self-organization of the cell population necessarily involves symmetry-breaking and subsequent patterning to generate spatially separated domains of different cell types. This patterned structure can then undergo morphogenetic rearrangements to acquire the 40, 41, 48, 193, 194 Use of human kidney organoids for the evaluation of nephrotoxicity 41, 193, 194 50, 197, 198 Mouse salivary gland organoids have been used to expand in vitro gland stem cells that restored salivary function in murine models of hyposalivation 50, 197 Human ASCs
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Neural retina
(NR). a multi-layered structure of the eye formed by the neuronal types responsible for light acquisition and conversion into neural signals.
Retinal pigmented epithelium
(RPe). a pigmented epithelium attached to the outside of the neural retina in the eye. it provides nutritional support to neural retina cells.
Starting from a homogeneous cell aggregate (optic cup organoids)
Starting from co-culture of different cell types (liver organoids from PSCs) final organoid architecture. In general, when an organoid derivation protocol starts from a single cell, an early step of cell expansion is required before self-organization can occur. At the opposite end of the spectrum, there are protocols that involve the co-culturing of cell types that have been separately pre-differentiated, which is the case for PSC-derived liver organoids 43 . In these protocols, the disparate cell identities are to a large extent already established; therefore, self-organization primarily involves cell sorting and subsequent architectural rearrangements (Fig. 1c) . The initial conditions of the cell population will also affect the range of applicability of an organoid as a biological model system. Indeed, organoids obtained through the co-culture of separately pre-established cell types are arguably less informative for studying organogenesis than models in which the different cell types are generated simultaneously and therefore have the potential to capture more comprehensively the transient developmental interactions that could occur between different progenitors during the formation of the organoid.
The characteristics of the final organoid also depend on the starting cell type. Organoids have been derived from ASCs 13, 17, 34, 44 (either as isolated cells or from dissected tissue fragments), PSCs 12, 32, 33, 45 or fetal progenitor cells 46, 47 . Some types of organoids have thus far been derived only from PSCs, including neuroectodermal organoids, such as optic cup 12 and cerebral organoids 14, 32 , and mesodermal kidney organoids 40, 48 . By contrast, organoids of surface ectoderm lineage (particularly glandular tissues) have been mainly derived from ASCs or dissociated adult tissues 34, [49] [50] [51] . The majority of organoids of the endodermal lineage have been derived from both PSCs and ASCs (Table 1) . Terminally differentiated cells reprogrammed to a tissue-specific ASC-like state have recently been used as an alternative source for derivation of epithelial mammary gland and pancreatic organoids 52 . Only a few examples of organoids derived from fetal progenitors have been published. Pancreatic organoids have been derived using cells dissociated from mouse fetal (embryonic day 10.5) dorsal pancreata 47 and fetal-type intestinal organoids have been obtained from dissociated human fetal intestinal tissue 46 . Because different cell types originate from distinct developmental stages, they will follow different paths (Fig. 2) ; therefore, the choice of the starting cell population is particularly important when studying mechanisms underlying organoid formation. Organoids derived from ASCs or adult tissue fragments are believed to mimic the homeostatic or regenerative conditions of their tissue of origin 2 . Thus, stem cells from organs that are characterized by continuous renewal throughout life, such as the epithelia of the small intestine 13 , colon 53 or stomach 54, 55 , generate organoids representing the homeostatic role of these cells in vivo. By contrast, organoids derived from tissues with a slow turnover 2 in which endogenous stem and/or progenitor cells presumably play a role only upon injury, such as in the pancreas or liver, are considered to be bona fide models of regeneration 56, 57 . Although this classification is clear in vivo, in vitro conditions can make the distinction between homeostasis-driven and regeneration-driven organoids tricky to determine. For example, it has been reported that intestinal organoid formation occurs through mechanisms that seem to be unnecessary for homeostasis in vivo but are activated under regenerative conditions 58 . Similarly, gastric organoids can be obtained from a starting population of cells that specifically expands in vivo upon injury 44 . While ASC-derived organoids are useful for answering questions about adult tissue biology, PSC-derived organoids are mainly used to study organogenesis and developmental events that lead to tissue formation (Fig. 2) . PSC-derived organoids very rarely reach an adult tissue stage in vitro and usually resemble fetal-stage tissues 12, 33, 45 (Fig. 2) . One possible reason for the limited maturation of PSC-derived organoids is the fact that development towards more mature cell types requires continuous culture for periods of time that typically exceed the capacity of the actual culturing methodologies 59 . Another possibility is that, in contrast to ASCderived organoids, cells in PSC-derived organoids are missing crucial interactions with other co-developing cell types because of our limited capacity to fully reconstruct embryonic developmental processes in vitro 60 . So-called embryonic organoid systems can be used to build more complete developmental models in vitro. These self-organizing PSC-derived structures, also termed 'embryoids' or 'gastruloids' , mimic in a very simplified way pre-implantation 61 and early post-implantation embryonic development [62] [63] [64] , establishment of body axes 65, 66 , gastrulation [65] [66] [67] [68] [69] [70] [71] and neural tube development 72, 73 . Whereas classic organoids are typically composed of a restricted subset of cell types from one germ layer, embryonic organoids are characterized by the coexistence of cells from multiple germ layers, as in real embryos. This feature adds a fascinating level of complexity and allows for the reproduction and in vitro study of the intricate interactions among different cell types in developmental processes.
Finally, fetal progenitor-derived organoids 46 ,47 start directly from fetal tissues, thus from a stage between ASCs and PSCs. Therefore, fetal organoids can be used to study more advanced stages of organogenesis than PSC-derived organoids. For example, enterospheres from fetal intestinal progenitors have been used to study their maturation towards adult intestinal organoids 46 . 
◀

Ureteric epithelium
Derivative of the intermediate mesoderm that contributes to the formation of the renal collecting ducts.
Metanephric mesenchyme
Derivative of the intermediate mesoderm that substantially contributes to the formation of the renal nephrons.
Antral
The identity of the gastric epithelium in the most distal part of the stomach, pertaining to an anatomical region that connects to the intestinal duodenum called the pyloric antrum.
Fundic
The identity of the gastric epithelium in the upper curvature of the stomach, pertaining to an anatomical region called the fundus of the stomach.
Mesodermal
Derived from the mesoderm, the middle embryonic germ layer that is formed upon gastrulation and will give rise to different adult tissues such as skeletal and cardiac muscle, smooth muscle, blood, cartilage, bones and dermis.
Surface ectoderm
The part of the embryonic ectoderm that lines the exterior of the embryo (the surface). Derivatives of the surface ectoderm include the epidermis with associated glands (including the mammary glands), sensory receptors, the epithelium of the oral and nasal cavity with associated glands and the cornea and the lens of the eye, among others.
Applications of organoids
Organoids as models of development, homeostasis and regeneration. Organoids recapitulate in vitro some principles of organ biology and provide simplified and readily accessible 'minimal systems' for discerning the relative contribution of different tissue components to complex morphogenetic processes (Fig. 3a) . Indeed, organoids have already revealed surprising mechanisms of tissue-autonomous self-organization in homeostasis, regeneration and development. These tissue-autonomous mechanisms would have been difficult to identify in vivo because of the potentially confounding influences of nearby tissues. For instance, in ASC-derived intestinal organoids, stem cells isolated from crypts re-establish an intestinal epithelium in the absence of a subepithelial mesenchymal compartment 13 , and in PSC-derived optic cup organoids, optic vesicles autonomously undergo morphogenesis without the need for signals from an overlying surface ectoderm 12 . A key feature of organoids is their greater experimental accessibility than mammalian animal models, which has contributed to a more in-depth understanding of organogenesis and adult organ biology. The capacity of mouse intestinal stem cells (ISCs) that express the Lgr5 gene to form self-renewing colonies has been shown to be dependent on Paneth cells, a neighbouring cell type of ISCs in the crypt 74 . Indeed, Paneth cells express high levels of WNT ligands, and WNT signalling is essential for ISC maintenance 75 . An elegant study used cells expressing a tagged WNT isoform to gain insights into the role of WNT gradients in intestinal biology 76 . The use of intestinal organoids in this study provided an experimentally amenable system to generate high-resolution information 76 . This work demonstrated that the WNT protein does not diffuse but is instead transferred from a Paneth cell to an adjacent ISC, and the WNT gradient is formed along the crypts by ISC division and dilution of membrane-bound WNT in daughter cells. Taken together, these observations indicate that Paneth cells act as localized sources of WNT signals for ISC self-renewal 76 and support a model in which spatial confinement of Paneth cells to the bottom of the crypt defines the physical separation between ISC self-renewal and differentiation. This physical separation was previously suggested by clonal analysis experiments on ISCs in vivo, which demonstrated that competition for occupancy of the crypt niche determined whether ISCs self-renewed or differentiated 77 .
Similarly, experiments possible only on optic cup organoids have provided insights into the mechanisms underlying optic cup morphogenesis, a process that involves invagination of the NR within the RPE. Treating mouse organoids at different phases of the conversion from optic vesicle to optic cup with drugs that inhibit either active cytoskeletal contraction or cell proliferation showed that optic cup morphogenesis is a multi-phase process. The process of vesicle invagination starts with domain-specific changes to mechanical properties, which are caused by cytoskeletal re-organization. These changes result in a reduction of contractility and thus rigidity in the NR and maintenance of high levels of contractility and rigidity in the RPE. In subsequent phases, the role of cell proliferation becomes 
Glandular tissues
epithelial tissues that produce and release biomolecules (hormones and growth factors, among others) into the bloodstream, in external or internal body cavities.
Endodermal
Derived from the endoderm, the most inner embryonic germ layer formed upon gastrulation, that will give rise to internal structures such as the epithelial lining of the respiratory and gastrointestinal tracts and of the urinary system.
Gastrulation a process that occurs during mammalian embryonic development in which the three germ layers (ectoderm, mesoderm and endoderm) form from the epiblast and arrange in space to generate a more defined body plan of the organism.
Enterospheres
Spherical epithelial cysts of fetal intestinal progenitors.
nature reviews | GeneTicS the study of disease mechanisms because they replicate the complexity of the in vivo disease phenotype while still retaining the accessibility of in vitro systems. c | Organoid biobanks could be used to identify drugs effective against a broad spectrum of disease phenotypes. d | In personalized medicine, patient-specific organoids can help identify the best drug for each patient. e | Organoids derived from healthy donor cells, or from patients after genetic correction, can be used as a source of cells or tissues for regenerative medicine purposes (the red star represents a pathological genetic mutation). EGF, epidermal growth factor.
or differences between humans and other species. For example, mouse embryos lacking the β-catenin gene, which encodes the core transcription factor of the WNT pathway, show a loss of fundic stomach identity and an expansion of the antral domain 42 . This result suggests a prominent role for WNT signalling in specifying fundic identity. To determine whether this might also be the case in human gastric patterning, hPSC-derived gastric organoids 33 at the posterior foregut stage were exposed to a WNT agonist, and expression analysis of domain-specific markers confirmed a switch from antral to fundic identity 42 . Whereas gastric organoids highlight common developmental mechanisms between humans and mice, optic cup organoids underline human-specific developmental features 12, 78 . Indeed, human optic cup organoids take much longer than their mouse counterparts to reach comparable developmental stages. They are also larger and have a thicker NR than mouse organoids. These species-specific differences are confirmed by the analysis of human and mouse embryonic tissues 78 . Moreover, optic cup organoids have revealed species-specific morphogenetic mechanisms. Normally, during the progression from optic vesicle to cup, the NR changes from an apically concave to an apically convex structure. In mouse organoids, this so-called eversion requires continuity between the NR and the RPE. Indeed, mouse NRs dissociated from the RPE at the vesicle stage do not undergo eversion 12, 78 . By contrast, human NRs dissociated from the RPE at the vesicle stage are still able to autonomously undergo eversion through a myosin-independent mechanism mediated by integrins 78 . Finally, organoids can be used as minimal systems to study the principles of self-organization. An interesting example comes from research on embryonic organoid models of gastrulation (gastruloids) [66] [67] [68] [69] [70] [71] . In these systems, cells adopt spatially organized fates as a result of uniform exposure to a morphogen, which implies they self-organize 65, 67, [69] [70] [71] . In some of these studies, a combination of in silico mathematical models and experimental data has been used to test the capacity of specific molecular mechanisms to recapitulate the outcome of self-organization 67, 70 . These models were then used to successfully predict the behaviour of gastruloids in response to varying the starting conditions 67, 70 . In general, mathematical modelling could help to elucidate the mechanisms underlying self-organization and to predict the effect of different conditions on the outcome, thus increasing our ability to control complex multicellular behaviours in vitro.
Organoids for disease modelling, drug discovery and personalized medicine. An obvious advantage of organoid cultures for disease modelling, compared with traditional cell cultures of a single cell type, is their ability to mimic pathologies at the organ level (Fig. 3b) . Moreover, organoids derived from human ASCs or induced PSCs (iPSCs) can serve as models for human diseases by recapitulating specific human features that are relevant for translational studies. A wide range of organoid-based disease models that reproduce genetic diseases 32, [79] [80] [81] , host-pathogen interactions 33, 55, [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] or cancer 21, 55, [95] [96] [97] [98] have already been developed and provide proof of principle that organoids can reproduce certain well-known pathological features (Fig. 3b) . For example, human gastric organoids microinjected with Helicobacter pylori bacteria successfully reproduce the typical signs of this bacterial infection 33, 55 . This model is particularly relevant because species-specific features of the stomach make animal models unsuitable for studying human gastric pathologies. Indeed, H. pylori infection in mice does not progress to ulceration and cancer as it does in humans 55 . The idea that organoids can model human pathologies has opened the door to studies on the feasibility of drug testing and screening applications (Fig. 3c) . For instance, drugs for treating Zika virus infections were recently screened in hPSC-derived cortical neural progenitor cells and validated in parallel in organoids and mouse models, confirming that organoids are a valid alternative system for testing drugs against this pathology 99 . Pioneering results have also been reported for the use of organoids in testing drugs for cystic fibrosis (CF), a genetic disease caused by defects in the CFTR gene 100 . Patient-derived intestinal organoids carrying CFTR mutations possibly represent the only example of organoids that have already been applied to personalized medicine (Fig. 3d) . Organoids derived from one patient with a very rare CFTR mutation with no known treatment were used to screen existing CF drugs. They showed responsiveness to a drug already used to treat other CF mutations, thereby allowing the patient access to treatment with beneficial outcomes 101 . The screen used a standardized functional test based on cAMP-induced organoid swelling as a readout for restored CFTR functionality, which was optimized on intestinal organoids from both mice and patients for at least five different mutations 79 . Another milestone in the use of organoids for drug screening is the development of organoid-based high-throughput screening (HTS) paradigms. An interesting example of HTS has been recently reported for human kidney organoids 102 , in which automated organoid derivation and assessment of drug effects have been demonstrated.
An emerging application for organoids is the creation of organoid biobanks for different pathologies (Fig. 3c) . Such biobanks will eventually facilitate the design of powerful screening platforms that cover a wide range of the worldwide population genetic variance. For example, the creation of CF intestinal organoid biobanks 103 could potentially cover most of the spectrum of CFTR mutations. The generation of biobanks could be even more important for cancer, a class of pathologies that are characterized by a virtually unlimited number of mutations 104, 105 . Cancer cells have been used to generate in vitro structures in a similar fashion to organoids. However, these structures, just like the tumours from which they are derived, often lack the typical architectural organization of organoids 21, 53, [95] [96] [97] . These models are usually defined as cancer organoids or, perhaps more appropriately, 'tumouroids' . Initial attempts have been made to establish tumouroid biobanks for colon cancer 104, 105 , which is very common in 
Optic vesicles
embryonic epithelial vesicles evaginating from the forebrain neuroepithelium that will give rise to the optic cup. in organoids, they are the vesicular structures forming at early stages of organoid development, before the morphological changes that will give rise to the final optic cup structure.
Personalized medicine a medical procedure in which the therapy and/or treatment is tailored to a specific patient. 106 , thereby highlighting the predictive potential of cancer organoids, and a library of 22 patient-derived bladder cancer organoids has been established that recapitulate the histopathological and molecular hallmarks of the respective parental tumours 107 .
Organoid biobanks
Organoids from patient-derived iPSCs could also be used to study pathologies for which defined genetic causes have not yet been discovered. Complex pathologies with high patient-to-patient variability might be good candidates for these studies. Indeed, new biological insights into autism spectrum disorder (ASD) were recently generated by modelling ASD in brain organoid cultures; this approach uncovered in part a pathogenic mechanism that involves overproduction of GABAergic neurons in response to FOXG1 overexpression 108 (Fig. 3b ).
All these results are highly encouraging and suggest that organoids could reduce the amount of required animal testing in accordance with the 3R principles 109 .
Regenerative medicine. Organoids are emerging as a promising source of transplantable tissues and functional cell types for cell therapy in regenerative medi cine (Fig. 3e) . Proof-of-concept experiments have already been reported in animal models. For example, retinal sheets have been derived from mouse embryonic stem cells (ESCs) or mouse iPSCs using a modi fied optic cup organoid protocol 12 and transplanted into a mouse model of retinal degeneration. The transplanted tissue gave rise to mature photoreceptors and, in some cases, established synaptic connections with the host cells 110 and recovered light responsiveness 111 . Retinal tissues generated from human ESC-derived organoids also survive, mature and demonstrate a degree of integration with the host tissue when transplanted into rat and primate models of retinal degeneration 112 . Intestinal organoids grown from dissociated mouse colon epithelia or from single stem cells and transplanted into mice were able to regenerate colonic mucosa injuries to various degrees 113 . Similarly, transplanted enterospheres grown from fetal intestinal progenitor cells integrate into injured mouse colon and differentiate in vivo 46 . Transplantation experiments in animal models have also been reported for liver 57, 80 and kidney 48 organoids. Indeed, the ability of organoids to provide cells that are competent to reconstruct organ function and potentially also a niche that protects the graft from the hostile patholo gical environment could represent an advantage in cell therapy applications compared with transplantation of cells deprived of their physiological context. This hypothesis is supported by a study that reported that 3D-structured grafts integrate into the host mouse retina better than dissociated embryonic retinal progenitors 110 . Finally, the use of organoids for regenerative medicine could be used in combination with in vitro genetic correction strategies to enable the autologous replacement of tissues affected by genetic disorders. In a proof-of-principle study, CRISPR-Cas9-mediated gene editing was used to correct the most common CFTR mutation leading to CF, a deletion of phenylalanine at position 508, in patient-derived ISCs, which were then used to generate functional organoids 114 (Fig. 3e) .
Although preliminary, taken together, these results are highly promising and indicate that the clinical transplantation of organoid-derived cells and tissues might be feasible.
Towards a new generation of organoids
The applications discussed above rely on the reproducible generation of organoids with a high level of structural and functional similarity with real organs to be used as faithful substitutes for in vivo studies. Although the organoid field is moving ahead at an impressive speed, bridging the gap with native organs will be the main challenge in the decades to come. A general limitation of all organoid derivation protocols is the high variability of the phenotypes that they can produce. Organoid-to-organoid reproducibility is a limitation for many applications but is particularly problematic for translational studies, such as drug screening, in which a high intrinsic variability could mask the effect of a treatment. Moreover, different types of organoids recapitulate with different accuracy the cellular and architectural complexity of their respective organ. This characteristic applies to the capacity of an organoid to reproduce all cell types within a specific tissue as well as the different tissues of an organ. For example, whereas intestinal organoids from ASCs are exclusively composed of intestinal epithelium 13 , derivation of intestinal organoids from PSCs can also give rise to the intestinal mesenchyme 45 . Another important limitation, especially for PSC-derived organoids, is their low grade of maturation, which hinders their application as models for adult tissue biology. Below, we discuss how progress in other disciplines could help overcome these shortcomings (Fig. 4) .
In-depth characterization of organoids. Organoids are complex structures composed of different cell types arranged in 3D space but, for most systems, the identity of these cell types has not been thoroughly defined. This makes it difficult to determine how accurately an organoid represents native organ composition and architecture. Single-cell sequencing technologies provide a powerful way to relate the transcriptional profiles of organoids to those of targeted organs. This approach not only provides information on cellular identities within organoids but also can help to define the lineage trajectories of selected cell types. This type of analysis has already been conducted for cerebral organoids 115, 116 and liver organoids 117 , which have been shown to have 3R principles a framework for more humane animal research aimed at replacing, reducing and refining animal experimentation. similar gene expression profiles to fetal neocortex and fetal liver, respectively. As a result of a multi-laboratory project, stage-dependent transcriptome data from embryonic animal tissues are becoming available 118 , and this information will help reveal how faithfully organoids recapitulate developmental processes. Moreover, RNA tomography can generate cell transcriptional profiles with spatial resolution, thereby providing information on the position of different cell types within the organ architecture 119 . These impressive early efforts towards a deeper characterization of organoids will ultimately also contribute to the improved reproducibility of organoid cultures.
Improved organoid maturation.
As discussed above, a major shortcoming of PSC-derived organoids is their limited cell maturation. Indeed, organoids of this type usually resemble fetal tissues rather than adult ones. On the one hand, this might simply be due to the restricted lifespan of organoids, which limits their ability to reach later stages of development. On the other hand, it is possible that in vitro conditions lack specific in vivo environmental factors that promote organoid maturation. For example, brain organoids could require sensory stimulation for further maturation, which contributes to the shaping of neural circuits in vivo 120 . Lengthening the culture period is particularly crucial for human organo ids because they take much longer than mouse organoids to reach comparable stages 12, 78 . An obvious reason for the limited lifespan of organoids is that, once a certain size is reached, diffusion is unable to supply all the cells with sufficient nutrients to support continued development 90 . A possible solution to this problem could be the use of bioreactors that improve nutrient supply through constant culture spinning (Fig. 4a) . Bioreactors are extensively applied in the field of tissue engineering to introduce controlled changes of culture conditions, standardize them and scale up tissue production for regenerative medicine 121, 122 . Indeed, such bioreactors have extended the duration of brain organoid cultures from a couple of months to up to 1 year 123 and have resulted in structures that more closely resemble the developing human brain.
Vascularization of organoids could further improve their lifespan by distributing nutrients via capillaries, as occurs in vivo (Fig. 4h) . Emerging bioengineering approaches that have been developed to generate vascularized tissue-like structures include sacrificial moulds [124] [125] [126] and laser ablation 127 , which enable fabrication of channels within the culturing scaffold that can host endothelial cells and form perfusable vascular units. Alternatively, bioprinting methods 128, 129 have been used to control the position of endothelial cells in 3D-printed structures. Although these studies were conducted in simplified cellular systems, organoid culture could benefit from future improved versions of these methods.
Another strategy to promote vascularization of the growing tissue would be to integrate endothelial cells, or their progenitors, during organoid formation. This approach has been successfully applied to liver organoids: human endothelial cells were co-cultured with human mesenchymal stem cells and human iPSC-derived hepatic endoderm cells to form self-organizing liver buds with a microvascular network that rapidly connected to the host circulation upon transplantation into mice 43 ( Fig. 4g) . Alternatively, the desired organ-specific cells and vascular endothelial cells can be independently differentiated from PSCs and the endothelial cells then used to vascularize the organoid, as has been shown for human brain organoids 130 . Recently, it has been demonstrated that hPSC-derived cerebral organoids implanted into mouse brains can be vascularized by the host 131 . Interestingly, the host-vascularized organoid grafts survive for up to 233 days post-implantation and reach later stages of development than do stage-matched cerebral organoids cultured in vitro. They also have a higher number of mature neurons, mature astrocytes, microglia and cells expressing markers of dorso-cortical identity 131 . That organoids can acquire a more developed phenotype when transplanted in vivo has also been demonstrated for other organoids, such as liver 43 , intestine 132 and lung 133 , which suggests that exposure to in vivo systemic factors and vascularization promotes the growth and maturation of organoids. Nevertheless, full maturation of some tissues may require many years in vivo, such as the cerebral cortex, which continues to develop postnatally. The full development of such adult traits may require innovative strategies that artificially accelerate maturation processes. For organoids obtained from patient iPSCs, the modelling of age-related phenotypes is even more challenging. Indeed, reprogramming of adult cells tends to erase the original age-related traits 134 . Although not extended to organoids, the transient overexpression of progerin (a truncated form of lamin A) in patient iPSCs has been used to recapitulate age-related traits and has allowed in vitro modelling of pathological features of Parkinson disease 134 .
Improved organoid architecture. Self-organization can generate organoids with a 3D microanatomy that resembles that of in vivo organs, but their overall architecture usually differs greatly from real organs. To address this challenge, stem cell culture scaffolds with a topography matching that of a specific tissue could be used to improve organoid architecture and increase size (Fig. 4c) . For example, microstructured collagen gels that mimic the typical crypt anatomy of the colonic epithelium have been used to culture a self-renewing monolayer of human colonic cells 135 , and an architecture that mimics the crypt-villus structure has been used to culture human small intestinal stem cells 136 . At the microscale, organoid topology could be improved by adopting bioengineering approaches to better regulate self-organization and morphogenesis (for instance, by precisely controlling interactions between stem cells and the surrounding ECM). Most organoid protocols use naturally derived hydrogel matrices such as Matrigel. Although these matrices are extremely effective at promoting cell growth and self-organization, they limit the ability to direct organoid morphogenesis because they are ill-defined, suffer from lot-to-lot variability and do not support controlled modifications. They also contain animal-derived products, which are undesirable for clinical applications owing to risks of immunogen and pathogen transfer. To overcome these limitations, a wide range of synthetic, chemically defined hydrogels have been developed for 3D cell culture [137] [138] [139] [140] [141] [142] [143] [144] [145] , the chemical and physical properties of which can be controlled and optimized for specific purposes. Some of these materials have already proved their compatibility with specific organoids: cerebral organoids have been grown in hyaluronan-based hydrogels 37 and self-organizing neural tube cysts have been grown in poly(ethylene glycol) (PEG)-based hydrogels 72, 73 . Furthermore, human intestinal organoids grown on synthetic hydrogels have been successfully transplanted into mouse models of colonic mucosal wounds in proof-of-concept studies 146 . Recently, new hydrogel formulations have been developed for which the biochemical and biophysical properties can be modulated spatially and temporally 36, 147, 148 (Fig. 4b) , which potentially adds an interesting new layer of control over organoid morphogenesis. Indeed, it has been shown that the mechanical properties of synthetic hydrogels can be dynamically tuned to initially favour ISC expansion and subsequently trigger crypt emergence and give rise to fully developed intestinal organoids 36 (Fig. 4b) .
Other tools used in bioengineering could also be exploited to increase the control over organoid morphogenesis and self-organization but have not yet 
Sacrificial moulds
Templates used to form a structure; they are dissolved after the moulding process.
Laser ablation
The controlled removal of portions of a material through irradiation with a laser beam.
Bioprinting
The use of specialized 3D printing technologies to combine cells, biomolecules and biomaterials in 3D assemblies.
been applied to studies directly related to organoids. Such tools include hydrogels that permit instantaneous orthogonal modification of their biochemical and mechanical properties 147 , which could be used to dynamically regulate organoid morphogenesis and progressively guide them towards a desired architecture (Fig. 4b) . Another example is light-triggered photoablation 127 , which could be used to actively re-adapt the geometry of the matrix to control morphogenetic rearrangements and favour organoid growth. Alternatively, new chemically defined materials that mimic the viscoelastic behaviours of in vivo ECM [149] [150] [151] could improve organoid growth by continuously reacting and re-adapting to morphogenetic processes without the need for external triggers.
The ability to control how cells assemble (for instance, by positioning different cell types in conformations that bias cell type-specific spatial interactions) could also be used to extend the control over organoid self-organization (Fig. 4e) . Bioprinting methods developed to pre-establish the 3D spatial organization of cells into tissues could fit this purpose 152 , as could the more recently developed DNA-programmed assembly of cells (DPAC) approach, which exploits the complementarity of DNA oligo nucleotides 153 . Moreover, DPAC has been used to pattern mouse embryonic fibroblast clusters in a gel, allowing for predictable folding of collagen scaffolds 154 , showing its potential to directly influence morphogenetic processes.
Organoid morphogenesis is also likely to be improved by gaining better control over the spatial and temporal distribution of diffusible signalling molecules (Fig. 4d) . Indeed, whereas in vivo cell fate patterning is influenced by spatially localized signalling centres, in vitro signalling molecules are typically presented in a uniform fashion. Bioengineering methods that rely on microfluidic devices [155] [156] [157] or on local diffusion from microspheres 158 have been developed to reproduce gradients of signalling molecules in both 2D 156 and 3D cultures 155, 157, 158 . In the future, these technologies could be applied to better control cell fate patterning during organoid development. Alternatively, synthetic biology approaches could be used to re-engineer the genetic programmes underlying self-organization; in a demonstration of its feasibility, synthetic Notch receptors were used to direct mammalian cells into self-organized cell patterns 159, 160 . Finally, mathematical modelling could also help to define which factors play a role in a specific self-organization process 67, 70 . As discussed for the case of gastruloids, in silico models could predict the behaviour of an in vitro system upon exposure to specific stimulations 67, 70 . This approach could help to identify in silico the best strategies to obtain a desired outcome.
Approaches to improve organoids for disease modelling. Another limitation of organoids, particularly for disease modelling applications, is their inability to model multi-organ pathologies. Co-culturing approaches (Fig. 4g) could partially address this issue. An early example in this direction has been reported for hPSC-derived intestinal organoids and enteric neurons 161 . In this study, the authors observed that mutations in PHOX2B, a gene associated with Hirschsprung disease, limit the differentiation of the enteric neuronal population, resulting in poor development of the smooth muscle components associated with the intestinal organoid epithelium 161 . For those pathologies with a strong immune component, the inclusion of vascularized networks perfused with immune cells could be a good strategy. Moreover, current drug testing platforms could be improved by merging organoid cultures with organ-on-chip technologies 162 to generate 3D systems that re-create the crosstalk between different organs (Fig. 4f) . This approach could combine the advantages of the two systems, bridging the ability to have interconnected, minimal systems typical of organs-on-chip with the high in vivo faithfulness and functionality typical of organoids. Clearly, the use of structured organoids requires novel microchip concepts that could seamlessly integrate with the highly stereotypical organization of organoids. Another crucial aspect for drug screening and personalized medicine applications of organoids is the development of reliable assays with accurate readouts of effectiveness, such as the CTFR drug screening assay conducted on intestinal organoids 79 . Integration of biosensors into the culture system could provide dynamic, automated means to quantitatively measure physicochemical responses to drugs and to provide custom readouts for drug screening applications, similar to approaches already demonstrated for organ-on-chip technology 163 .
Conclusions
Organoids have the capacity to mimic specific aspects of the 3D architecture, cell type composition and functionality of real organs while maintaining the advantages of simplified and easily accessible cell culture models. As such, they hold great promise for a range of biological and biomedical applications. In studies of basic tissue and organ biology, the potential for exploiting organoids to recapitulate in vivo phenomena has already been clearly revealed. Perhaps the most exciting perspective in basic organoid research is the ability to study human development (and disease) without tissue accessibility constraints. However, although the use of organoids also addresses some ethical issues, the prospect of generating in vitro human embryo-like structures is not free from ethical concerns [164] [165] [166] . The path towards a broad-ranging translation of organoid technology into real-life preclinical and clinical applications is considerably more challenging. Nevertheless, as discussed above, studies are now emerging that demonstrate the potential of organoids in personalized medicine settings 101, 103 , drug discovery 99, 105, 106 , regenerative medicine and gene therapy 114 , suggesting that more widespread adoption of organoids in these fields will become a reality in the coming decades.
Much has already been achieved in revealing the amazing level of self-organization that stem cells can display when cultured under the appropriate 3D conditions and in expanding the list of organoid types. Groundbreaking explorative studies for the application of various organoid types have also been published. However, many limitations still exist. Major challenges include regulating self-organization to generate
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organoids that develop deterministically, robustly and to physiologically relevant shapes and sizes; prolonging organoid lifespan to create mature, functional tissues that reach homeostasis; and recapitulating multi-factorial pathologies by incorporating additional key tissue compartments of native organs (such as the vasculature or immune system). Overcoming these challenges will require a multidisciplinary approach, and lessons from the field of bioengineering are likely to be particularly impactful.
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